Open access peer-reviewed Edited Volume

COVID-19 Vaccines - Current State and Perspectives

Ibrokhim Y. Abdurakhmonov

Academy of Sciences of Uzbekistan

A leading biotechnologist, coordinating biotechnology science including COVID-19 vaccine development, laboratory studies, and clinical trials and production in Uzbekistan. Prof. Abdurakhmonov founded (2012) the Center of Genomics and Bioinformatics of Uzbekistan. He received a BS in Biotechnology from the National University, an MS in Plant Breeding from Texas A&M University, USA, a Ph.D. in Molecular Genetics, a Doctor of Science in Genetics, and a full professorship in Molecular Genetics.


Full Genome Sequencing Mutations and Genetic Variations Whole-Virus Inactivated and Live-Attenuated Recombinant Protein-Based WHO-Protocols Preclinical and Clinical Trials New Strain Protection Availability and Usage Side Effects Novel Designs Country Experiences Booster-Dose Injection

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

The sudden global spread of novel coronavirus strains infecting humans late in 2019 has become a global threat for humanity and started a new era of COVID-19 pandemics with unprecedented socio-economic challenges and social crisis due to long-term and periodic multiple lock-downs globally. The situation has been even more dangerous and risky in the background of limited knowledge in understanding of the virus, its infection and variability capacity as well as lack of drugs and protocols of treatment. One of the key solutions that the world aimed from the beginning of COVID-19 pandemics has been a hope for rapid development of COVID-19 vaccines in order to overcome the global spread of virus infection via forming herd immunity. Thanks to the scientific efforts of world research communities, within a short time and with a fast-track project approach, several novel COVID-19 vaccines have been developed and made available for massive vaccination worldwide. However, humanity still is in midst of these pandemics and there is a need for better knowledge, understanding, technology, and innovative solutions to battle against this virus and its novel variants. Therefore, this “COVID-19 vaccines–current state and perspectives” book volume aims to compile views and analysis of international scientific communities on the understanding of virus biology and genome helping to develop current and future vaccines, advantages and disadvantages as well as their protection capacity of different vaccine technologies, requirements for approval and massive use in the light of gained experiences of currently developed, approved and massively used COVID-19 vaccines.

This book will intend to provide the reader with a comprehensive overview of the current state-of-the-art in COVID-19 vaccines with the future perspectives and novel directions to develop novel vaccine technologies or innovative application protocols that effectively protect from reinfection with potentially new coronavirus variants.

Publishing process

Book initiated and editor appointed

Date completed: March 17th 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline for chapter proposals: May 24th 2022

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Register for the book

Approved chapters written in full and submitted

Deadline for full chapters: July 23rd 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: October 11th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: December 10th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Ibrokhim Y. Abdurakhmonov

Academy of Sciences of Uzbekistan

Ibrokhim Y. Abdurakhmonov received his B.S. (1997) in biotechnology from the National University, M.S. in plant breeding (2001) from Texas A&M University of USA, Ph.D. (2002) in molecular genetics, Doctor of Science (2009) in genetics, and full professorship (2011) in molecular genetics and molecular biotechnology from Academy of Sciences of Uzbekistan. He founded (2012) the Center of Genomics and Bioinformatics of Uzbekistan. He received the 2010 TWAS prize, and “ICAC Cotton Researcher of the Year 2013” for his outstanding contribution to cotton genomics and biotechnology. He was elected as The World Academy of Sciences (TWAS) Fellow (2014) and as a member (2017) of the Academy of Sciences of Uzbekistan. He was appointed (2017) as a Minister of Innovative Development of Uzbekistan.

View profile

Book chapters authored 12

Books edited 12

Introducing your Author Service Manager

Ms. Sara Debeuc

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question

Book will be abstracted and indexed in